A 45-year-old man from Shimla with advanced liver cirrhosis and dual food pipe obstructions underwent a successful endoscopic ...

Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis ...

Therefore, individual patients have varying degrees of various drivers ... and MASLD-associated hepatic fibrosis—increase the ...

Coronary artery disease (CAD) is increasingly observed in patients with liver cirrhosis. However, data on the incidence and ...

A new study finds that a blood test may be a more reliable indicator of liver disease than asking how much a person drinks.

The following is a summary of “Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated ...

All patients were ... July 25, 2024 — A new study brings researchers closer to better understanding the pathology of the fatty liver disease MASH, which stands for metabolic dysfunction ...

New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye disease.

A Wisconsin state trooper has received a new liver after living with a rare form of liver disease for more than a decade.

Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality ...

For those dealing with fatty liver disease, there’s welcome news to report. Earlier this year, the United States Food and ...

Ocaliva recently failed to secure the FDA’s traditional approval for primary biliary cholangitis due to safety concerns.